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ABSTRACT 30 
Local nerve inflammation (neuritis) leads to ongoing activity and axonal mechanical sensitivity (AMS) 31 
along intact nociceptor axons, and disrupts axonal transport.  This phenomenon forms the most 32 
feasible cause of radiating pain, such as sciatica.  We have previously shown that axonal transport 33 
disruption without inflammation or degeneration also leads to AMS, but does not cause ongoing 34 
activity at the time point when AMS occurs, despite causing cutaneous hypersensitivity. However, 35 
there have been no systematic studies of ongoing activity during neuritis or non-inflammatory 36 
axonal transport disruption. In this study, we present the time course of ongoing activity from 37 
primary sensory neurons following neuritis and vinblastine-induced axonal transport disruption. 38 
Whereas 24% of C/slow Aδ-fiber neurons had ongoing activity during neuritis, few (<10%) A- and C-39 
fiber neurons showed ongoing activity 1-15 days following vinblastine treatment.  In contrast, AMS 40 
increased transiently at the vinblastine treatment site, peaking on day 4-5 (28% of C/slow Aδ-fiber 41 
neurons) and resolved by day 15. Conduction velocities were slowed in all groups.  In summary, the 42 
disruption of axonal transport without inflammation does not lead to ongoing activity in sensory 43 
neurons, including nociceptors, but does cause a rapid and transient development of AMS. Since it is 44 
proposed that AMS underlies mechanically-induced radiating pain, and a transient disruption of 45 
axonal transport (as previously reported) leads to transient AMS, it follows that processes that 46 
disrupt axonal transport, such as neuritis, must persist to maintain AMS and the associated 47 
symptoms. 48 
 49 
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NEW AND NOTEWORTHY 51 
Many patients with radiating pain lack signs of nerve injury on clinical examination, but may have 52 
neuritis, which disrupts axonal transport. We have shown that axonal transport disruption does not 53 
induce ongoing activity in primary sensory neurons but does cause transient axonal mechanical 54 
sensitivity.  The present data complete a profile of key axonal sensitivities following axonal transport 55 
disruption.  Collectively, this profile supports that an active peripheral process is necessary for 56 
maintained axonal sensitivities. 57 
 58 
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INTRODUCTION 64 
Conditions that cause radiating pain remain prevalent. Examples of such conditions include non-65 
specific arm or back pain, sciatica, fibromyalgia, whiplash associated disorder, diabetes, complex 66 
regional pain syndrome, and endometriosis (Dilley and Greening 2012; Dyck et al. 2000; Janig and 67 
Baron 2003; Loeser 1985; Waddell 1987; Woertgen et al. 1998; Zager et al. 1998). Many of these 68 
patients lack signs of a nerve injury on clinical examination. Instead, these patients may have 69 
inflamed nerves (i.e. neuritis) that are otherwise intact and are considered normal using typical 70 
clinical tests.  Magnetic resonance imaging studies in some of these patients have identified 71 
increases in T2-weighted signal intensity along nerve trunks that are consistent with neuritis (Dilley 72 
et al. 2011; Greening et al. 2018).  73 
A rat model of neuritis has given much of our understanding about the mechanisms that underlie 74 
pain in these patients.  In this model, animals develop transient behavioral sensory hypersensitivities 75 
to tactile and thermal stimuli in the absence of axonal degeneration (Bove et al. 2003; Chacur et al. 76 
2001; Eliav et al. 1999; Pulman et al. 2013).  At some time points following neuritis induction, the 77 
axons of intact nociceptors fire spontaneously, respond to direct mechanical stimulation at the site 78 
of inflammation (Bove et al. 2003; Dilley et al. 2005; Richards and Dilley 2015), and become sensitive 79 
to noxious inflammatory chemicals (Govea et al. 2017).  Such ectopic activity and sensitivity 80 
constitute the most feasible source of afferent nociceptor activity contributing to spontaneous pain 81 
and mechanically-evoked radiating pain that are reported in patients in the absence of nerve injury 82 
(Dilley and Greening 2012). This activity may also contribute to the afferent barrage that is reputed 83 
to drive central mechanisms that cause cutaneous hypersensitivities (Campbell and Meyer 2006; 84 
Gracely et al. 1992; Woolf 2011; Xie et al. 2005).  85 
We have shown that neuritis disrupts fast axonal transport along intact sensory axons, and that such 86 
disruption leads to axonal sensitivities (Dilley and Bove 2008a; Dilley et al. 2013). We have 87 
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hypothesized that the mechanisms underlying these sensitivities involve the accumulation and 88 
insertion of ion channels at the site of disruption. The effects of axonal transport disruption along 89 
intact axons can be examined by applying low doses of the vinca alkaloid, vinblastine, to the rat 90 
sciatic nerve (Dilley and Bove 2008a; Fitzgerald et al. 1984). At low doses, perineural vinblastine 91 
disrupts microtubule polymerization without causing axonal degeneration or inflammation (Dilley 92 
and Bove 2008a; Fitzgerald et al. 1984; Kashiba et al. 1992; Katoh et al. 1992; Zhuo et al. 1995), 93 
which allows axonal transport disruption to be examined in the absence of these potentially 94 
confounding factors. Using this model, we have shown that localized vinblastine treatment causes 95 
the development of a transient tactile-evoked cutaneous hypersensitivity (Dilley et al. 2013). At 96 
approximately the peak of this pain behavior (day 4-5), intact C-fiber neurons develop axonal 97 
mechanical sensitivity (AMS) at the treatment site (Dilley and Bove 2008a; Dilley et al. 2013). In a 98 
previous study, ongoing activity from A- or C- fiber axons was not increased at this time point, which 99 
contrasts from neuritis and nerve injury models where it is a major feature (Boucher et al. 2000; 100 
Bove and Dilley 2010; Kajander et al. 1992; Tal and Eliav 1996).  101 
Both neuritis and vinblastine-induced axonal transport disruption are short-lived phenomena (Bove 102 
et al. 2009; Dilley et al. 2013), but patient symptoms are often chronic.  This inconsistency has led to 103 
the suggestion that patients may have a persistent peripheral stimulus.  To determine whether such 104 
altered nociceptor activities require an active stimulus, we have performed a detailed assessment of 105 
the time course of ongoing activity in these models.  We also present the temporal profile of 106 
vinblastine-induced AMS, to compare with the ongoing activity.  Together, the data from the present 107 
and past experiments complete the profile of ectopic activity and sensitivity, which informs 108 
peripheral mechanisms of radiating pain.  109 
  110 
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METHODS 111 
 Animals and surgery  112 
Experiments were carried out in strict accordance with the UK Animals (Scientific Procedures) Act 113 
(1986) and Home Office guidelines. Formal approval was also obtained from the University of Sussex 114 
Animal Welfare Ethical Review Board. Adult male Sprague Dawley rats (n = 62; 250-500 g; Charles 115 
River Laboratories, Kent, UK) were used in this study. Rats were given ad libitum access to food and 116 
water. Animals were monitored daily. 117 
Vinblastine was applied to the sciatic nerve of adult rats (n = 32) as previously described (Dilley and 118 
Bove 2008a). Under general anesthesia (1.75% isoflurane in oxygen), the left sciatic nerve was 119 
exposed by blunt dissection. An 8 mm length was cleared from its connective tissue, which allowed a 120 
short length of sterile parafilm (6 x 20 mm; Sigma Aldrich, Dorset, UK) to be positioned under the 121 
nerve to prevent leakage of vinblastine onto the surrounding tissue. The sciatic nerve was loosely 122 
wrapped with a strip of sterile Gelfoam (5 x 5 x 10 mm; SpongostanTM; Ferrosan, Denmark) saturated 123 
in 0.1 mM vinblastine (Sigma Aldrich, Dorset, UK; diluted 0.9% w/v saline). Both the Gelfoam and 124 
parafilm were removed after 15 min.  The nerve was thoroughly rinsed with sterile saline and the 125 
muscle and skin were closed using 4/0 monofilament sutures (Vicryl; Ethicon, West London, United 126 
Kingdom). The saline group (n = 9) underwent identical surgery, but instead the Gelfoam was 127 
saturated with 0.9% w/v saline alone. 128 
Neuritis was induced as previously described (n = 13) (Dilley and Bove 2008b). The left sciatic nerve 129 
was exposed by blunt dissection and an 8 mm length was cleared from the surrounding connective 130 
tissue. A sterile strip of Gelfoam (5 x 5 x 10 mm) saturated in 50% complete Freund’s adjuvant 131 
(diluted in sterile 0.9% w/v saline) was loosely wrapped around the nerve. The muscle and skin were 132 
closed using 4/0 monofilament sutures.  133 
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 134 
Electrophysiology 135 
Single-unit extracellular electrophysiological recordings were made from A- and C-fiber axons in the 136 
L5 dorsal root as previously described (Bove et al. 2003). The L5 dorsal root innervates much of the 137 
plantar surface of the foot that was examined during behavioral testing. Experiments were carried 138 
out at 2 hours to 15 days following vinblastine treatment (n = 32), neuritis (n = 13) and saline 139 
treatment (n = 9), and in untreated animals (n = 9). Briefly, animals were deeply anesthetized (1.5 140 
g/kg 25% w/v urethane intraperitoneally) and the body temperature was maintained at 37°C using a 141 
rectal thermistor probe attached to a feedback controlled heat mat (Harvard Apparatus, Kent, UK). A 142 
mid-sagittal skin incision was made in the lumbar region of the back and a laminectomy was 143 
performed from the L2 to L5 vertebrae. The surrounding skin was sutured to a metal ring to form a 144 
pool. The dura mater was cut to expose the caudal end of the spinal cord and cauda equina, and the 145 
pool was filled with mineral oil warmed to 37°C. The temperature of the pool was monitored during 146 
each experiment and was topped up with warmed mineral oil when necessary. The ipsilateral L5 147 
dorsal root was identified and cut just before it enters the spinal cord, and loosely placed onto a 148 
glass platform (9 mm x 5 mm). Individual fine filaments were teased from the cut end of the nerve 149 
with finely sharpened forceps and carefully positioned on a bipolar recording electrode. In the mid-150 
thigh, the sciatic nerve was exposed and the surrounding skin flaps were stitched to a metal ring to 151 
form a second mineral oil pool. Ongoing activity and AMS were assessed in different animals 152 
because repeated mechanical stimulation of the sciatic nerve at the treatment site can lead to the 153 
development of ongoing activity (Dilley et al. 2005). Receptive fields were also not examined during 154 
experiments to assess levels of ongoing activity, since noxious mechanical stimulation that is 155 
necessary to activate the terminals of nociceptors can cause ongoing activity (Bove and Dilley 2010; 156 
Richards et al. 2011).  157 
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To measure C-fiber conduction velocities (<2 m/s), a bipolar stimulating electrode was positioned 158 
under the L5 dorsal root, and activity evoked by electrical stimulation using a constant-voltage 159 
isolated stimulator (square wave pulses; 0.5 ms duration, 30-50 V amplitude; Digitimer, 160 
Hertfordshire, United Kingdom). We have previously confirmed that the majority of neurons in the 161 
L5 dorsal root conduct through the sciatic nerve in the mid-thigh (i.e. through the treatment site) 162 
(Dilley et al. 2013). To measure A-fiber conduction velocities (>2 m/s), bipolar stimulating electrodes 163 
were positioned under the sciatic nerve immediately distal to the treatment site, and activity evoked 164 
by electrical stimulation at this site (square wave pulses; 0.05 ms duration, 3-10 V amplitude). During 165 
these stimuli, the limb was held in place by a noose around the foot. It should be noted that 166 
muscular contractions of the foot during electrical stimulation at A-fiber strength were only small, 167 
whereas stimulation at C-fiber strength would lead to substantial movement artifacts. The long 168 
conduction distance (range: 61-88 mm) allowed identification of individual A-fiber neurons. For each 169 
recording, the amplitude of the electrical stimulus was increased until the maximum number of 170 
waveforms was evoked. Only neurons with easily identifiable waveforms were examined. The 171 
number of waveforms on each filament ranged from 1 to 7. Action potentials were amplified (1-2 K), 172 
band-pass filtered (10-5000 Hz) and monitored with an oscilloscope. Neuronal activity was digitized, 173 
recorded and analyzed with Spike 2 software (Cambridge Electronic Designs, Cambridge, UK). At the 174 
end of an experiment, the sciatic nerve and L5 dorsal root were removed and the conduction 175 
distance was measured. Conduction velocities of each neuron were calculated from the conduction 176 
latency and conduction distance. 177 
In experiments to evaluate ongoing activity, identified neurons were recorded for 3 min. Neurons 178 
that fired at least once per minute were considered to exhibit ongoing activity (Bove and Dilley 179 
2010). Muscle spindles, identified by high frequency position- and movement-dependent repetitive 180 
firing, were excluded from the data analysis. Neurons with ongoing activity were identified as either 181 
A- or C-fiber neurons by spike shape. C-fiber neurons typically had a longer duration and were often 182 
biphasic compared to A-fiber neurons, which were monophasic (Dilley et al. 2005).  183 
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In the experiments to evaluate AMS, A-fiber neurons were not examined, since AMS in the Aβ 184 
population is rarely observed following vinblastine treatment (unpublished observations) or in the 185 
neuritis model (Bove et al. 2003). In the thigh, the sciatic nerve was exposed and a plastic platform 186 
(9 mm × 5 mm), notched to accommodate the nerve, was placed under the nerve with the 187 
treatment site in its center. Receptive fields for isolated neurons were searched below the knee 188 
using mechanical stimuli. Most receptive fields were located by squeezing the periphery, using either 189 
fingers or forceps. The loose property of the skin was exploited to carefully discriminate 190 
cutaneous versus deep fields (Bove et al. 2003). Cutaneous neurons had receptive fields that 191 
remained associated with the skin, whereas deep neurons (i.e. neurons that innervate muscles, 192 
tendons and joints) had receptive fields that remained in the same underlying spot irrespective of 193 
the skin position. For example, if a neuron responded to pinching a fold of skin, and maintained 194 
similar responsiveness when this fold was displaced, it was concluded that its receptive field was 195 
cutaneous. In contrast, if the repeated application of the effective stimulus to same underlying point 196 
produced a similar neuronal response despite displacement of the overlying skin, it was concluded 197 
that the receptive field was deep (e.g. in muscle). After identification of a receptive field, the 198 
conduction velocity of the neuron was determined by electrically stimulating the dorsal root while 199 
mechanically stimulating the receptive field.  If the neuron fired to mechanically-evoked stimulation 200 
of the receptive field immediately prior to the electrical stimulation of the nerve, the same neuron 201 
evoked by the electrical stimulus would be delayed or would not be initiated (i.e. the electrical 202 
stimulus occurred during the refractory period). 203 
Mechanical stimulation of the nerve was manually applied using a silicone probe as previously 204 
described (Bove et al. 2003; Dilley and Bove 2008a; b). The tip of the probe was conical shaped and 205 
cut at the end to form a flat footprint approximately 5 x 3.5 mm. The mechanical stimulus was 206 
applied for 1-2 sec successively along the length of nerve that was located on the notched platform 207 
(i.e. the treatment site or equivalent length in untreated animals). The force applied with the probe 208 
was <20 cN (as measured on an electronic scale). Using the probe in this manner does not interrupt 209 
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the conduction of action potentials (i.e. cause damage to axons), confirmed by repeated activation 210 
of each neuron at its receptive field following axonal mechanical sensitivity testing. The conduction 211 
velocity of axons that were mechanically sensitive was determined by electrically stimulating the 212 
dorsal root while mechanically stimulating the treatment site as described above.  213 
 214 
Data analysis 215 
Data were tested for normality using Shapiro-Wilk tests. Comparisons between the proportions of 216 
neurons with ongoing activity or AMS were made using Fisher’s exact tests. Conduction velocities of 217 
A- and C-fiber neurons and rates of ongoing activity from C-fiber neurons were compared between 218 
time points and to saline treatment using Kruskal-Wallis tests followed by Dunn’s post hoc tests. Due 219 
to the small number of A-fiber neurons with ongoing activity, rates could not be statistically 220 
compared. Comparisons of conduction velocities between neurons with and without AMS were 221 
made using Mann-Whitney tests. Conduction velocities and rates of ongoing data are presented as 222 
median +/- interquartile range (IQR). 223 
  224 
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RESULTS 225 
Conduction velocities 226 
Conduction velocity data are summarized in Fig. 1. Recordings were made from a total of 2124 227 
neurons in the L5 dorsal root following vinblastine, neuritis, and saline treatment, and in untreated 228 
animals. Histograms of the conduction velocities are shown in Fig. 1A and B. Based on the 229 
conduction velocities, neurons were characterized as either C/slow Aδ- (0.2-2.1 m/s; n = 1212) or 230 
Aα/β-fiber neurons (>10 m/s; n = 912) (Waddell et al. 1989).  231 
In the untreated group, the median conduction velocity of the C/slow Aδ- fiber neurons was 0.58 232 
m/s (IQR = 0.29; combined data from AMS and ongoing activity experiments). Following vinblastine 233 
treatment, neuritis and saline treatment, there was a significant slowing of conduction 3-4 hours 234 
postoperative compared to the untreated group (p < 0.05, Kruskal-Wallis test; p < 0.001, Dunn’s post 235 
hoc tests).  In the vinblastine treated group, conduction was also slowed at 4-5 and 12-15 days 236 
following surgery (p < 0.05, Dunn’s post hoc tests). Following neuritis, conduction was slowed at all 237 
of the time points examined (p < 0.01, Dunn’s post hoc tests). The maximum slowing was at 3-4 238 
hours postoperative following vinblastine treatment (19.7% compared to untreated; median = 0.47 239 
m/s (IQR = 0.16)) and neuritis (41.2% compared to untreated; median = 0.34 m/s (IQR = 0.22); Fig. 240 
1C).  241 
In the untreated group, the median conduction velocity of the Aα/β-fiber neurons was 33.01 m/s 242 
(IQR = 12.78). Following both vinblastine and saline treatment, the conduction velocities of the Aαβ-243 
fiber neurons were comparable to the untreated group at the time points examined. Following 244 
neuritis, conduction velocities were significantly reduced at 3-4 hours and 1-2 days postoperative (p 245 
< 0.05, Kruskal-Wallis test; p < 0.01, Dunn’s post hoc tests). The maximum reduction was at 3-4 246 
hours following treatment (20.8% compared to untreated; median = 26.16 m/s (IQR = 8.81) Fig. 1D). 247 
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Ongoing activity  248 
The proportion of C/slow Aδ-fiber neurons in each group with ongoing activity is summarized in Fig. 249 
2A. Ongoing activity developed in 5.3% of C/slow Aδ-fiber neurons in the untreated group, with a 250 
median firing rate of 0.60 (IQR = 1.03) Hz. Following vinblastine treatment, the proportions of C/slow 251 
Aδ-fiber neurons with ongoing activity ranged from 6.0 to 10.8% at the time points examined, which 252 
were not significantly different from the untreated group (p > 0.24, comparing individual time points 253 
to untreated) or following saline treatment (p > 0.12 at 3-4 hours and 4-5 days postoperative, 254 
Fisher’s exact tests). The median rate of ongoing activity in these neurons was < 0.35Hz, which was 255 
comparable between time points (p = 0.21, Kruskal-Wallis test; Table 1). In contrast to vinblastine 256 
treatment, there was a significant increase in ongoing activity from C/slow Aδ- fiber neurons 257 
following neuritis on day 4-5 postoperative, with 23.9% (21/88) of neurons firing spontaneously 258 
(p<0.05 Fisher’s exact test, compared to untreated and saline-treated). The rates of ongoing activity 259 
following neuritis at 1-2 days postoperative were significantly increased compared to 3-4 hours and 260 
12-15 days postoperative (p < 0.05, Kruskal-Wallis test; p <0.05, Dunn’s post hoc tests). The firing 261 
patterns were all irregular (e.g. Fig. 2B). 262 
The proportion of Aα/β-fiber neurons in each group with ongoing activity is summarized in Fig. 3A. 263 
Ongoing activity was present in only 1 Aα/β-fiber neuron (1.3%, 1/79 neurons) in the untreated 264 
group, which had an irregular slow (0.02 Hz) firing pattern (Fig. 4B). Following vinblastine treatment, 265 
ongoing activity was observed in 1.1 to 5.3% of Aα/β-fiber neurons at the time points examined, 266 
which was not significantly different from the untreated group (p > 0.20 comparing individual time 267 
points to untreated) or to saline treatment (p > 0.68 at 3-4 hours and 4-5 days postoperative, 268 
Fisher’s exact tests). Following neuritis, ongoing activity was observed in 1.3 to 6.5% of Aα/β-fiber 269 
neurons, which was also not significantly different from the untreated group (p > 0.14 comparing 270 
individual time points to untreated) or to saline treatment (p > 0.44 at 3-4 hours and 4-5 days 271 
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postoperative, Fisher’s exact tests). Median rates of ongoing activity in all Aα/β-fiber neurons were 272 
low (median rate < 0.24 Hz; Table 1). Firing patterns were all irregular (e.g. Fig. 3B). 273 
 274 
Axonal mechanical sensitivity 275 
The proportion of C/slow Aδ-fiber neurons in each group with deep and cutaneous receptive fields 276 
that developed AMS is summarized in Fig. 4. All of the neurons had receptive fields below the knee. 277 
The receptive fields of each of these neurons had a high mechanical threshold, responding to firm 278 
squeezing of the receptive field. Axonal mechanical sensitivity testing was repeatable and activation 279 
of the receptive field before and following testing confirmed that the axons remained intact. The 280 
majority of AMS ‘hotspots’ were either immediately proximal to, or at, the treatment site. No AMS 281 
‘hotspots’ were found distally. AMS did not develop in the untreated (0/28 neurons) or saline-282 
treated groups (0/23 neurons). Following vinblastine treatment, AMS was detected only in neurons 283 
with deep receptive fields (i.e. in muscles or joints), that is, none of the neurons with cutaneous 284 
receptive fields exhibited AMS. Axonal mechanical sensitivity developed rapidly, with 15.8% (6/38) 285 
of all C-fiber neurons responding to direct mechanical stimulation at the treatment site on day 1-2 286 
postoperative (p<0.05 compared to untreated (0/28), Fisher’s exact test). The proportion of neurons 287 
with AMS reached a maximum on day 4-5, with 27.6% (8/29) of all neurons responding to 288 
mechanical stimulation (p<0.01 and p<0.05 compared to untreated and saline-treated on day 4-5 289 
postoperative (0/23) respectively, Fisher’s exact test). On day 8-9, 8.3% (2/24) of all neurons 290 
developed AMS. By day 13-15, AMS had completely reversed with 0% (0/26) of neurons being 291 
mechanically sensitive. The median conduction velocity of the neurons that developed AMS was 292 
0.55 (IQR 0.26) m/s (n = 16), which was not significantly different from those that were not 293 
mechanically sensitive (combined median for 1-2, 4-5 and 8-9 days postoperative = 0.60 (0.26) m/s; 294 
n = 75; p = 0.34, Mann-Whitney test). 295 
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DISCUSSION  296 
Our experiments show that inflammation of the axons of C/slow Aδ-fiber-neurons, which are likely 297 
to be nociceptors, causes transient ongoing activity that reaches a maximum on day 4-5 following 298 
induction and decreases to control levels after 2 weeks. The observation that vinblastine treatment 299 
does not evoke a statistically significant increase in ongoing activity at any postoperative point 300 
supports that inflammation is key to the development of axonal ongoing activity.  Combined, these 301 
observations support that if undamaged peripheral nociceptors exhibit ongoing activity, there must 302 
be a persistent source of inflammation.  The findings may be directly applicable to patients with 303 
persistent radiating pain, which may be due to focal inflammation anywhere along the clinically 304 
implicated peripheral nerve.  The results also clearly demonstrate the vulnerability and adaptability 305 
of small diameter unmyelinated axons to subtle changes in their environment.   306 
Since neuritis disrupts axonal transport, we have proposed that the cellular components necessary 307 
for the development of ongoing activity are transported by fast axonal transport and accumulate at 308 
the inflamed site. These cellular components might include immune receptors and/or ion channels, 309 
such as hyperpolarization activated channels, which have also been implicated in the mechanisms of 310 
ongoing activity (Emery et al. 2011; Richards and Dilley 2015; Weng et al. 2012).  The lack of an 311 
increase in ongoing activity in A- or C-fiber neurons up to 15 days following vinblastine-induced 312 
axonal transport disruption is consistent with the necessity for inflammation to activate the altered 313 
axons; vinblastine is in fact anti-inflammatory by virtue of its anti-mitotic properties. Furthermore, 314 
the sensitivity of C-fiber axons following the direct application of noxious inflammatory chemicals to 315 
the vinblastine treatment site (Govea et al. 2017) is consistent with the immune-mediated activation 316 
of accumulated cellular components.  317 
Data from this study add to the “peripheral generator” theory, which proposes that an ongoing or 318 
intermittent afferent barrage from nociceptors is required to maintain the cutaneous symptoms 319 
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associated with neuropathic pain (Campbell and Meyer 2006; Gracely et al. 1992; Woolf 2011; Xie et 320 
al. 2005). The lack of increased ongoing activity from Aα/β- or C/slow Aδ-fiber neurons at any of the 321 
examined time points following vinblastine treatment suggests that the previously reported tactile-322 
evoked cutaneous hypersensitivity in this model may be driven by AMS, since the time course of this 323 
sensitivity is comparable to the hypersensitivity (Dilley et al. 2013).  324 
The appearance and resolution of C-fiber AMS is consistent with the time course of slowed axonal 325 
transport that we have shown in this model (Dilley et al. 2013). Axons that were mechanically 326 
responsive were most likely nociceptors, since a high mechanical threshold was required to 327 
stimulate the receptive fields. The time course of AMS contrasts from neuritis, where similar activity 328 
persists beyond one month (Dilley and Bove 2008b). This difference most likely reflects the longer 329 
duration of axonal transport disruption following neuritis (Dilley et al. 2013). 330 
The transient development of neuritis-induced ongoing activity and AMS, and vinblastine-induced 331 
AMS, contrasts from the reported chronicity in patients.  In both models, altered nociceptor activity 332 
occurs when there is an active peripheral stimulus. When the stimulus is absent, such as when 333 
axonal transport has recovered and levels of specific inflammatory chemicals have resided (Pulman 334 
et al. 2013), sensitivities resolve.  These observations support that in patients, a peripheral stimulus, 335 
such as inflammation, must be active to cause persistent and spontaneous pain, and movement-336 
evoked radiating pain. This hypothesis is consistent with MRI findings of possible nerve inflammation 337 
in patients with chronic whiplash associated disorder (Greening et al. 2018), and also with the 338 
persistent symptoms in a rat model of repetitive motion disorders, where neuritis is a prominent 339 
feature (Barbe et al. 2013). Therefore, persistent nerve inflammation, due to injury to surrounding 340 
soft tissues or direct irritation of the affected nerve, is a probable cause of prolonged focal axonal 341 
transport disruption that may underlie altered nociceptor activity.  342 
In summary, altered nociceptor activity may cause persistent and spontaneous pain (mainly through 343 
the development of nociceptor ongoing activity) and radiating pain (through the development of 344 
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AMS).  Many patients with these symptoms lack signs of nerve injury on routine clinical examination. 345 
In such patients, the underlying mechanisms may involve inflammation-induced axonal transport 346 
disruption. A detailed examination of ongoing activity following neuritis and vinblastine-induced 347 
axonal transport disruption has shown that neuritis causes the transient development of ongoing 348 
activity in C/slow Aδ-fiber neurons. The lack of ongoing activity in A- or C-fiber neurons at any of the 349 
examined time points following vinblastine treatment is consistent with the need for inflammation 350 
to drive ongoing activity.  It also raises the question as to whether such activity is essential for the 351 
development of the associated cutaneous hypersensitivities. The present data also show that AMS 352 
develops rapidly following vinblastine treatment but is relatively short-lived. The present work adds 353 
to our understanding of the relative contributions of ectopic activity and reinforces the 354 
underestimated role of AMS in neuropathic pain mechanisms. It also supports that for pain to 355 
persist, an active stimulus that causes altered axonal transport, such as neuritis, must also persist. 356 
Concerning animal welfare, treating nerves with low doses of vinblastine provides a less severe 357 
model to examine the role of axonal transport disruption in neuropathic pain mechanisms. It avoids 358 
cutting nerves, which can lead to adverse effects, and allows axonal transport disruption along intact 359 
axons to be explored.  360 
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FIGURE LEGENDS 460 
 461 
Fig. 1. Conduction velocities of C- and A-fiber neurons. (A, B) Histogram of the conduction velocities 462 
of (A) C/slow Aδ- and (B) Aα/β-fiber neurons for each group. (C, D) Median conduction velocities of 463 
(C) C/slow Aδ- and (D) Aα/β -fiber neurons for each group at different postoperative time points. 464 
Saline-treated animals were only examined at 3-4 hours postoperative and on days 4-5.  The number 465 
of C/slow Aδ- and Aα/β-fiber neurons in each group at each time point ranged from 72 to 147. 466 
C/slow Aδ-fiber neurons were characterized by electrical stimulation of the L5 dorsal root (see Fig. 467 
2), whereas Aα/β-fiber neurons were characterized by electrical stimulation of the sciatic nerve (see 468 
Fig. 3). * p < 0.05, ** p <0.01, *** p < 0.001, **** p < 0.0001 compared to untreated; ††† p < 0.001, 469 
†††† p < 0.0001 compared to saline treatment (Kruskal-Wallis test followed by Dunn’s post hoc test). 470 
Error bars = IQR. 471 
 472 
Fig. 2.  Development of ongoing activity in C/slow Aδ- fiber neurons.  (A) The percentage of ongoing 473 
activity is shown for the untreated, saline-treated, vinblastine-treated and neuritis groups at 474 
different postoperative time points. Numbers of neurons with ongoing activity are given. A 475 
schematic of the electrophysiology set-up is also shown. The recording (Rec) and stimulating (stim) 476 
sites at the L5 dorsal root are indicated. The treatment site is shown along the sciatic nerve in the 477 
mid-thigh (greyed area). *** p < 0.001 (Fisher’s exact test). (B) Typical patterns of ongoing activity. 478 
Inserts: expanded waveforms.  479 
 480 
Fig. 3. Development of ongoing activity in Aα/β-fiber neurons were characterized by electrical 481 
stimulation of the L5 dorsal root (see Fig. 2), whereas A-fiber neurons were characterized by 482 
electrical stimulation of the sciatic nerve (see Fig. 3).-fiber neurons.  (A) The percentage of ongoing 483 
activity is shown for the untreated, saline-treated, vinblastine-treated and neuritis groups at 484 
different time points postoperative. Numbers of ongoing neurons are given. A schematic of the 485 
electrophysiology set-up is also shown. The recording site at the L5 dorsal root is indicated (Rec). The 486 
nerve was stimulated along the sciatic nerve in the mid-thigh (Stim), immediately distal to the 487 
treatment site (greyed area).  (B) Typical patterns of ongoing activity. Ongoing spindles are also 488 
present in the untreated and neuritis traces (smaller units). Insert: expanded waveforms.  489 
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 490 
Fig. 4. Development of axonal mechanical sensitivity in C/slow Aδ- fiber neurons. (A) The percentage 491 
of AMS in deep and cutaneous (denoted by D and C respectively) innervating neurons is shown for 492 
the untreated group and the vinblastine-treated groups at different time points postoperative. 493 
Horizontal lines indicate the combined percentage of axons with mechanical sensitivity for deep and 494 
cutaneous innervating neurons. Numbers of neurons with AMS innervating deep and cutaneous 495 
structures are given. A schematic of the electrophysiology set-up is also shown. The recording (Rec) 496 
and stimulating (Stim) sites at the L5 dorsal root are indicated. The treatment site is shown along the 497 
sciatic nerve in the mid-thigh (greyed area). A notched platform was positioned under the treatment 498 
site to support the nerve during AMS testing.  *p<0.05, ** p<0.01 compared to untreated, for 499 
percent of neurons innervating deep structures (Fisher’s exact test). † p<0.05, †† p<0.01 compared 500 
to untreated, for all neurons (combined deep + cutaneous). (B) The response pattern of AMS is 501 
linked to the mechanical stimulus. Horizontal lines above trace represent the duration of the 502 
mechanical stimuli.  Inserts: expanded waveforms.   503 
 504 
  505 
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TABLES 506 
Table 1. Rates (Hz) of ongoing activity in C/slow Aδ-  and A- fiber neurons. 507 
C/slow Aδ- fiber 
neurons 
A-fiber neurons 
Treatment Time PO Median IQR Median  IQR 
Untreated 0 0.60 1.03 0.02 0.00 
Vinblastine 3-4hr 0.35 0.62 0.14 0.28 
 1-2d 0.17 0.28 0.11 0 
 4-5d 0.26 0.48 0.04 0.08 
 12-15d 0.08 0.54 0.24 0.03 
Neuritis 3-4hr 0.11 0.19 0.04 0.01 
 1-2d 1.27* 1.31 0.09 0.17 
 4-5d 0.55†# 1.53 0.11 0.09 
 12-15d 0.10 0.13 0.02 0.00 
Saline 3-4hr 0.14 0.10 0.03 0.15 
 4-5d 0.47 0.56 0.21 0.20 
* p< 0.05 compared to 3-4 hours and 12-15 days postoperative  ; † p< 0.05 compared to 3-4 hours 508 
postoperative (Kruskal-Wallis test followed by Dunn’s post hoc tests). # Based on 20 neurons (Rate 509 
could not accurately be determined for one neuron). PO postoperative, hr = hour, d = day. 510 
 511 




